drugset / Trial / NCT06591377

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

NCT06591377

RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

Timeline

Start
2024-08-10
Primary completion
2025-09-19
Completion
2025-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilostazol Small molecule 100 mg
Comparator Ticagrelor Small molecule 90 mg
Comparator Aspirin Small molecule 75 mg

Indications